Articles & Issues

Alert me when new Articles in Press are available. Add Articles in Press Alert   Request Articles in Press Alert via email or RSS Feed   Request RSS feed of Articles in Press

124 Articles

Article Title Author(s) Type (Status) Available Online
Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer

DOI: 10.1016/j.ejca.2012.04.014

Angela van Baardwijk, Bart Reymen, Stofferinus Wanders, Jacques Borger, Michel Öllers, Anne-Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Frank Peters, Philippe Lambin, Dirk De Ruysscher et al. Full-length article
(In Press Corrected Proof)
21 May 2012
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

DOI: 10.1016/j.ejca.2012.04.011

Roger Stupp, Eric T. Wong, Andrew A. Kanner, David Steinberg, Herbert Engelhard, Volkmar Heidecke, Eilon D. Kirson, Sophie Taillibert, Frank Liebermann, Vladimir Dbalý, Zvi Ram, J. Lee Villano, Nikolai Rainov, Uri Weinberg, David Schiff, Lara Kunschner, Jeffrey Raizer, Jerome Honnorat, Andrew Sloan, Mark Malkin, Joseph C. Landolfi, Franz Payer, Maximilian Mehdorn, Robert J. Weil, Susan C. Pannullo, Manfred Westphal, Martin Smrcka, Lawrence Chin, Herwig Kostron, Silvia Hofer, Jeffrey Bruce, Rees Cosgrove, Nina Paleologous, Yoram Palti, Philip H. Gutin et al. Full-length article
(In Press Corrected Proof)
21 May 2012
Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: A population-based study

DOI: 10.1016/j.ejca.2012.04.004

B.L. Den Oudsten, M.J. Traa, M.S.Y. Thong, H. Martijn, I.H.J.T. De Hingh, K. Bosscha, L.V. van de Poll-Franse et al. Full-length article
(In Press Corrected Proof)
21 May 2012
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function

DOI: 10.1016/j.ejca.2012.04.002

Rafael Morales-Barrera, Joaquim Bellmunt, Cristina Suárez, Claudia Valverde, Marta Guix, Cesar Serrano, Manuel Gallén, Joan Carles et al. Full-length article
(In Press Corrected Proof)
18 May 2012
Quality-of-life among head and neck cancer survivors at one year after treatment – A systematic review

DOI: 10.1016/j.ejca.2012.04.005

W.K.W. So, R.J. Chan, D.N.S. Chan, B.G.M. Hughes, S.Y. Chair, K.C. Choi, C.W.H. Chan et al. Full-length article
(In Press Corrected Proof)
14 May 2012
Clear cell sarcoma of the kidney: A review

DOI: 10.1016/j.ejca.2012.04.009

S.L.M. Gooskens, R. Furtwängler, G.M. Vujanic, J.S. Dome, N. Graf, M.M. van den Heuvel-Eibrink et al. Full-length article
(In Press Corrected Proof)
14 May 2012
The EORTC QLQ-OH17: A supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients

DOI: 10.1016/j.ejca.2012.04.003

Marianne Jensen Hjermstad, Mia Bergenmar, Sheila E. Fisher, Sébastien Montel, Ourania Nicolatou-Galitis, Judith Raber-Durlacher, Susanne Singer, Irma Verdonck-de Leeuw, Joachim Weis, Noam Yarom, Bente B. Herlofson et al. Full-length article
(In Press Corrected Proof)
10 May 2012
Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer

DOI: 10.1016/j.ejca.2012.04.007

J. Faivre, V. Dancourt, B. Denis, E. Dorval, C. Piette, Ph. Perrin, J.M. Bidan, C. Jard, S. Jung, R. Levillain, J. Viguier, J.F. Bretagne et al. Full-length article
(In Press Corrected Proof)
09 May 2012
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis

DOI: 10.1016/j.ejca.2012.04.001

Bradley J. Monk, Thomas J. Herzog, Stanley B. Kaye, Carolyn N. Krasner, Jan B. Vermorken, Franco M. Muggia, Eric Pujade-Lauraine, Youn C. Park, Trilok V. Parekh, Andres M. Poveda et al. Full-length article
(In Press Corrected Proof)
30 April 2012
Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: A systematic review and meta-analysis

DOI: 10.1016/j.ejca.2012.03.018

Zhenjie Wu, Jun Ouyang, Zhenhua He, Sen Zhang Full-length article
(In Press Corrected Proof)
30 April 2012
Stem cells in breast tumours: Are they ready for the clinic?

DOI: 10.1016/j.ejca.2012.03.019

Matthew P. Ablett, Jagdeep K. Singh, Robert B. Clarke Full-length article
(In Press Corrected Proof)
30 April 2012
Specific-site methylation of tumour suppressor ANKRD11 in breast cancer

DOI: 10.1016/j.ejca.2012.03.023

Sue Ping Lim, Nick C. Wong, Rachel J. Suetani, Kristen Ho, Jane Lee Ng, Paul M. Neilsen, Peter G. Gill, Raman Kumar, David F. Callen et al. Full-length article
(In Press Corrected Proof)
26 April 2012
Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammography

DOI: 10.1016/j.ejca.2012.03.011

Vivian van Breest Smallenburg, Lucien E.M. Duijm, Adri C. Voogd, Frits H. Jansen, Marieke W.J. Louwman et al. Full-length article
(In Press Corrected Proof)
18 April 2012
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11years using propensity score matching

DOI: 10.1016/j.ejca.2012.03.020

I. Le Ray, S. Dabakuyo, G. Crehange, M. Bardou, L. Arnould, J. Fraisse, P. Fumoleau, B. Coudert, S. Causeret, P. Arveux, P. Maingon, F. Bonnetain et al. Full-length article
(In Press Corrected Proof)
18 April 2012
Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria

DOI: 10.1016/j.ejca.2012.03.015

Ting Hu, Shuang Li, Yile Chen, Jian Shen, Xiong Li, Kecheng Huang, Ru Yang, Li Wu, Zhilan Chen, Yao Jia, Shaoshuai Wang, Xiaodong Cheng, Xiaobing Han, Zhongqiu Lin, Hui Xing, Pengpeng Qu, Hongbing Cai, Xiaojie Song, Xiaoyu Tian, Hongbing Xu, Jun Xu, Qinghua Zhang, Ling Xi, Dongrui Deng, Hui Wang, Shixuan Wang, Weiguo Lv, Changyu Wang, Xing Xie, Ding Ma et al. Full-length article
(In Press Corrected Proof)
16 April 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?

DOI: 10.1016/j.ejca.2012.03.016

F. Bonnetain, J.F. Bosset, J.P. Gerard, G. Calais, T. Conroy, L. Mineur, O. Bouché, P. Maingon, O. Chapet, L. Radosevic-Jelic, N. Methy, L. Collette et al. Full-length article
(In Press Corrected Proof)
16 April 2012
Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial

DOI: 10.1016/j.ejca.2012.03.013

Srinivas Kondalsamy-Chennakesavan, Monika Janda, Val Gebski, Jannah Baker, Alison Brand, Russell Hogg, Thomas W. Jobling, Russell Land, Tom Manolitsas, Marcelo Nascimento, Deborah Neesham, James L. Nicklin, Martin K. Oehler, Geoff Otton, Lewis Perrin, Stuart Salfinger, Ian Hammond, Yee Leung, Peter Sykes, Hextan Ngan, Andrea Garrett, Michael Laney, Tong Yow Ng, Karfai Tam, Karen Chan, David H. Wrede, Selvan Pather, Bryony Simcock, Rhonda Farrell, Gregory Robertson, Graeme Walker, Anthony McCartney, Andreas Obermair et al. Full-length article
(In Press Corrected Proof)
16 April 2012
Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus

DOI: 10.1016/j.ejca.2012.03.010

Michael Stahl, Nils Lehmann, Martin K. Walz, Martin Stuschke, Hansjochen Wilke et al. Full-length article
(In Press Corrected Proof)
13 April 2012
Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome

DOI: 10.1016/j.ejca.2012.03.012

Donnette A. Dabydeen, Jyothi P. Jagannathan, Nikhil Ramaiya, Katherine Krajewski, Fabio A.B. Schutz, Daniel C. Cho, Ivan Pedrosa, Toni K. Choueiri et al. Full-length article
(In Press Corrected Proof)
09 April 2012
Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European database

DOI: 10.1016/j.ejca.2012.03.008

Carlos A. Garcia-Etienne, Mariano Tomatis, Joerg Heil, Kay Friedrichs, Rolf Kreienberg, Andreas Denk, Marion Kiechle, Fatemeh Lorenz-Salehi, Rainer Kimmig, Günter Emons, Mahmoud Danaei, Volker Heyl, Uwe Heindrichs, Christoph J. Rageth, Wolfgang Janni, Lorenza Marotti, Marco Rosselli del Turco, Antonio Ponti, eusomaDB Working Group et al. Full-length article
(In Press Corrected Proof)
06 April 2012
Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations

DOI: 10.1016/j.ejca.2012.02.049

Nicola L. Schoenewolf, Christian Bull, Benedetta Belloni, David Holzmann, Sabina Tonolla, Roland Lang, Daniela Mihic-Probst, Christian Andres, Reinhard Dummer et al. Full-length article
(In Press Corrected Proof)
05 April 2012
Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: Results from a retrospective, longitudinal survey (MELODY study)

DOI: 10.1016/j.ejca.2012.03.003

K. Johnston, A.R. Levy, P. Lorigan, M. Maio, C. Lebbe, M. Middleton, A. Testori, C. Bédane, C. Konto, A. Dueymes, U. Sbarigia, M. van Baardewijk et al. Full-length article
(In Press Corrected Proof)
05 April 2012
Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?

DOI: 10.1016/j.ejca.2012.03.004

Laetitia Huiart, Anne-Déborah Bouhnik, Dominique Rey, Carole Tarpin, Camille Cluze, Marc Karim Bendiane, Patrice Viens, Roch Giorgi et al. Full-length article
(In Press Corrected Proof)
05 April 2012
Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysis

DOI: 10.1016/j.ejca.2012.03.001

Jiangbo Liu, Qingyong Ma, Min Zhang, Xinshuai Wang, Dong Zhang, Wei Li, Fengfei Wang, Erxi Wu et al. Full-length article
(In Press Corrected Proof)
30 March 2012
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis

DOI: 10.1016/j.ejca.2012.03.006

Maider Ibarrola-Villava, Hui-Han Hu, Mickaël Guedj, Lara P. Fernandez, Vincent Descamps, Nicole Basset-Seguin, Martine Bagot, Armand Benssussan, Philippe Saiag, Maria Concetta Fargnoli, Ketty Peris, Jose A. Aviles, Ana Lluch, Gloria Ribas, Nadem Soufir et al. Full-length article
(In Press Corrected Proof)
30 March 2012
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer

DOI: 10.1016/j.ejca.2012.03.002

Rupert Bartsch, Zsuzsanna Bago-Horvath, Anna Berghoff, Catharina DeVries, Ursula Pluschnig, Peter Dubsky, Margaretha Rudas, Robert M. Mader, Andrea Rottenfusser, Florian Fitzal, Michael Gnant, Christoph C. Zielinski, Guenther G. Steger et al. Full-length article
(In Press Corrected Proof)
29 March 2012
Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminase

DOI: 10.1016/j.ejca.2012.02.067

Dora Ling, Glenn M. Marshall, Pei Y. Liu, Ning Xu, Charlotte A. Nelson, Siiri E. Iismaa, Tao Liu et al. Full-length article
(In Press Corrected Proof)
29 March 2012
TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells

DOI: 10.1016/j.ejca.2012.03.005

Ling Xu, Ye Zhang, Jing Liu, Jinglei Qu, Xuejun Hu, Fan Zhang, Huachuan Zheng, Xiujuan Qu, Yunpeng Liu et al. Full-length article
(In Press Corrected Proof)
29 March 2012
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials

DOI: 10.1016/j.ejca.2012.02.057

Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier, Fortunato Ciardiello, Steffen Heeger, Michael Schlichting, Ilhan Celik, Claus-Henning Köhne et al. Full-length article
(In Press Corrected Proof)
27 March 2012
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies

DOI: 10.1016/j.ejca.2012.02.063

Yi Chen, Xiaolin Wang, Jianhua Wang, Zhiping Yan, Jianjun Luo et al. Full-length article
(In Press Corrected Proof)
26 March 2012
Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer

DOI: 10.1016/j.ejca.2012.02.051

E. Tanis, C.J.H. van de Velde, H. Bartelink, M.J. van de Vijver, H. Putter, J.A. van der Hage et al. Full-length article
(In Press Corrected Proof)
26 March 2012
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium

DOI: 10.1016/j.ejca.2012.01.038

Michele L. Coté, Mei Liu, Stefano Bonassi, Monica Neri, Ann G. Schwartz, David C. Christiani, Margaret R. Spitz, Joshua E. Muscat, Gad Rennert, Katja K. Aben, Angeline S. Andrew, Vladimir Bencko, Heike Bickeböller, Paolo Boffetta, Paul Brennan, Hermann Brenner, Eric J. Duell, Eleonora Fabianova, John K. Field, Lenka Foretova, Søren Friis, Curtis C. Harris, Ivana Holcatova, Yun-Chul Hong, Dolores Isla, Vladimir Janout, Lambertus A. Kiemeney, Chikako Kiyohara, Qing Lan, Philip Lazarus, Jolanta Lissowska, Loic Le Marchand, Dana Mates, Keitaro Matsuo, Jose I. Mayordomo, John R. McLaughlin, Hal Morgenstern, Heiko Müeller, Irene Orlow, Bernard J. Park, Mila Pinchev, Olaide Y. Raji, Hedy S. Rennert, Peter Rudnai, Adeline Seow, Isabelle Stucker, Neonila Szeszenia-Dabrowska, M. Dawn Teare, Anne Tjønnelan, Donatella Ugolini, Henricus F.M. van der Heijden, Erich Wichmann, John K. Wiencke, Penella J. Woll, Ping Yang, David Zaridze, Zuo-Feng Zhang, Carol J. Etzel, Rayjean J. Hung et al. Full-length article
(In Press Corrected Proof)
21 March 2012
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection – Results from a clinic-based longitudinal cohort

DOI: 10.1016/j.ejca.2012.02.065

Hie-Won Hann, Xiaoying Fu, Ronald E. Myers, Richard S. Hann, Shaogui Wan, Su Hee Kim, Natalie Au, Jinliang Xing, Hushan Yang et al. Full-length article
(In Press Corrected Proof)
21 March 2012
Cancer screening and health system resilience: Keys to protecting and bolstering preventive services during a financial crisis

DOI: 10.1016/j.ejca.2012.02.060

Jose M. Martin-Moreno, Ahti Anttila, Lawrence von Karsa, Jose L. Alfonso-Sanchez, Lydia Gorgojo et al. Full-length article
(In Press Corrected Proof)
19 March 2012
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

DOI: 10.1016/j.ejca.2012.02.062

Chiara Laezza, Alba D’Alessandro, Simona Paladino, Anna Maria Malfitano, Maria Chiara Proto, Patrizia Gazzerro, Simona Pisanti, Antonietta Santoro, Elena Ciaglia, Maurizio Bifulco, Endocannabinoid Research Group et al. Full-length article
(In Press Corrected Proof)
16 March 2012
Effects of the combination of RAD001 and docetaxel on breast cancer stem cells

DOI: 10.1016/j.ejca.2012.02.053

Xiaobei Zhang, Sheng Zhang, Yan Liu, Jingjing Liu, Yi Ma, Yuanxi Zhu, Jin Zhang et al. Full-length article
(In Press Corrected Proof)
15 March 2012
Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis

DOI: 10.1016/j.ejca.2012.02.009

Yan Liu, Chung-Chou H. Chang, Gary M. Marsh, Felicia Wu Full-length article
(In Press Corrected Proof)
14 March 2012
Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

DOI: 10.1016/j.ejca.2012.02.059

K. Cocks, M.T. King, G. Velikova, G. de Castro, M. Martyn St-James, P.M. Fayers, J.M. Brown et al. Full-length article
(In Press Corrected Proof)
14 March 2012
miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2

DOI: 10.1016/j.ejca.2012.02.007

Lingchao Chen, Xiaofeng Wang, Hanbing Wang, Yongli Li, Wei Yan, Lei Han, Kailiang Zhang, Junxia Zhang, Yongzhi Wang, Yan Feng, Peiyu Pu, Tao Jiang, Chunsheng Kang, Chuanlu Jiang et al. Full-length article
(In Press Corrected Proof)
09 March 2012
Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort

DOI: 10.1016/j.ejca.2012.02.002

Heidi A. van Vugt, Ries Kranse, Ewout W. Steyerberg, Henk G. van der Poel, Martijn Busstra, Paul Kil, Eric H. Oomens, Igle J. de Jong, Chris H. Bangma, Monique J. Roobol et al. Full-length article
(In Press Corrected Proof)
09 March 2012
Opposite effects of microchimerism on breast and colon cancer

DOI: 10.1016/j.ejca.2012.02.006

Mads Kamper-Jørgensen, Robert J. Biggar, Anne Tjønneland, Henrik Hjalgrim, Niels Kroman, Klaus Rostgaard, Casey L. Stamper, Anja Olsen, Anne-Marie N. Andersen, Vijayakrishna K. Gadi et al. Full-length article
(In Press Corrected Proof)
07 March 2012
Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells

DOI: 10.1016/j.ejca.2012.01.032

Nadine Andrae, Elmar Kirches, Roland Hartig, Daniela Haase, Gerburg Keilhoff, Thomas Kalinski, Christian Mawrin et al. Full-length article
(In Press Corrected Proof)
05 March 2012
Successful centralisation of patients with vulvar carcinoma: A population-based study in The Netherlands

DOI: 10.1016/j.ejca.2012.01.030

Loes C.G. van den Einden, Katja K.H. Aben, Leon F.A.G. Massuger, Dick Johan van Spronsen, Joanne A. de Hullu et al. Full-length article
(In Press Corrected Proof)
05 March 2012
Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies

DOI: 10.1016/j.ejca.2011.12.034

Linda J. Wedlake, Foteini Silia, Barbara Benton, Amyn Lalji, Karen Thomas, David P. Dearnaley, Peter Blake, Diana Tait, Vincent S. Khoo, H. Jervoise N. Andreyev et al. Full-length article
(In Press Corrected Proof)
05 March 2012
High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion

DOI: 10.1016/j.ejca.2012.02.005

Ha-Jeong Kim, Hye-Kyung Jeon, Young Jae Cho, Young Ae Park, Jung-Joo Choi, In-Gu Do, Sang Young Song, Yoo-Young Lee, Chel Hun Choi, Tae-Joong Kim, Duk-Soo Bae, Jeong-Won Lee, Byoung-Gie Kim et al. Full-length article
(In Press Corrected Proof)
05 March 2012
Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden

DOI: 10.1016/j.ejca.2012.01.035

Andreas Thorstenson, Ola Bratt, Olof Akre, Henrik Hellborg, Lars Holmberg, Mats Lambe, Anna Bill-Axelson, Pär Stattin, Jan Adolfsson et al. Full-length article
(In Press Corrected Proof)
02 March 2012
Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?

DOI: 10.1016/j.ejca.2012.01.031

Claes G. Tropé, Mari B. Elstrand, Berit Sandstad, Ben Davidson, Halldis Oksefjell et al. Full-length article
(In Press Corrected Proof)
01 March 2012
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth

DOI: 10.1016/j.ejca.2012.01.037

Fieke Lamers, Linda Schild, Ilona J.M. den Hartog, Marli E. Ebus, Ellen M. Westerhout, Ingrid Ora, Jan Koster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar et al. Full-length article
(In Press Corrected Proof)
27 February 2012
Modest improvement in 20years of kidney cancer care in the Netherlands

DOI: 10.1016/j.ejca.2012.01.033

Saskia A.M. van de Schans, Katja K.H. Aben, Peter F.A. Mulders, John B.A.G. Haanen, Carla van Herpen, Rob H.A. Verhoeven, Henrike E. Karim-Kos, Egbert Oosterwijk, Lambertus A.L.M. Kiemeney et al. Full-length article
(In Press Corrected Proof)
27 February 2012
Carcinoma of endocrine organs: Results of the RARECARE project

DOI: 10.1016/j.ejca.2012.01.029

Jan Maarten van der Zwan, Sandra Mallone, Boukje van Dijk, Magdalena Bielska-Lasota, Renée Otter, Roberto Foschi, Eric Baudin, Thera P. Links, The RARECARE WG et al. Full-length article
(In Press Corrected Proof)
24 February 2012
Is there a general autoantibody signature for cancer?

DOI: 10.1016/j.ejca.2012.01.017

Nicole Ludwig, Andreas Keller, Petra Leidinger, Christian Harz, Christina Backes, Hans-Peter Lenhof, Eckart Meese et al. Full-length article
(In Press Corrected Proof)
24 February 2012
Embryonal cancers in Europe

DOI: 10.1016/j.ejca.2011.12.027

Gemma Gatta, Andrea Ferrari, Charles A. Stiller, Guido Pastore, Gianni Bisogno, Annalisa Trama, Riccardo Capocaccia, The RARECARE Working Group et al. Full-length article
(In Press Corrected Proof)
22 February 2012
Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989–2008

DOI: 10.1016/j.ejca.2012.01.003

L.M. Hollestein, E. de Vries, T. Nijsten Full-length article
(In Press Corrected Proof)
20 February 2012
Does baseline total testosterone improve the yielding of prostate cancer screening?

DOI: 10.1016/j.ejca.2012.01.025

Francisco Botelho, Francisco Pina, Luís Figueiredo, Francisco Cruz, Nuno Lunet et al. Full-length article
(In Press Corrected Proof)
20 February 2012
Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: Analysis of response and progression-free survival in the RECORD-1 study

DOI: 10.1016/j.ejca.2012.01.027

Stéphane Oudard, Rokhaya Thiam, Laure S. Fournier, Jacques Medioni, Michele Lamuraglia, Florian Scotte, Elizabeth Fabre, Dennis Kim, Euloge Kpamegan, Ashok Panneerselvam, Charles A. Cuenod et al. Full-length article
(In Press Corrected Proof)
20 February 2012
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer

DOI: 10.1016/j.ejca.2011.12.029

Jing Xu, Susan Müller, Sreenivas Nannapaneni, Lin Pan, Yuxiang Wang, Xianghong Peng, Dongsheng Wang, Mourad Tighiouart, Zhengjia Chen, Nabil F. Saba, Jonathan J. Beitler, Dong M. Shin, Zhuo (Georgia) Chen et al. Full-length article
(In Press Corrected Proof)
17 February 2012
TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid

DOI: 10.1016/j.ejca.2012.01.028

Muhammad Imran, Tae Jun Park, In Kyoung Lim Full-length article
(In Press Corrected Proof)
16 February 2012
Cancer risk and prevention in a globalised world: Solving the public policy mismatch

DOI: 10.1016/j.ejca.2012.01.019

R. Sullivan, L. Homberg, A.D. Purushotham Discussion
(In Press Corrected Proof)
15 February 2012
Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?

DOI: 10.1016/j.ejca.2012.01.026

Michelle M. Kim, Karen E. Hoffman, Lawrence B. Levy, Steven J. Frank, Thomas J. Pugh, Seungtaek Choi, Quynh N. Nguyen, Sean E. McGuire, Andrew K. Lee, Deborah A. Kuban et al. Full-length article
(In Press Corrected Proof)
15 February 2012
Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma

DOI: 10.1016/j.ejca.2012.01.015

Liping Chen, Qi Zhang, Wenjun Chang, Yan Du, Hongwei Zhang, Guangwen Cao et al. Full-length article
(In Press Corrected Proof)
13 February 2012


Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are three types of "Articles in Press":
  • Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
  • Uncorrected proofs: these are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
  • Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.